Rays of Belief Limited, the parent company of the Mom’s Belief brand, is preparing to enter the Indian mainboard IPO market with a fresh issue of up to 52.30 lakh equity shares. The company operates in the specialised neurodevelopmental care segment, providing personalised intervention programmes for children with conditions such as autism, ADHD, Down syndrome, cerebral palsy, intellectual disabilities, learning disabilities and developmental delays.
The IPO is scheduled to open on September 1, 2026, and close on September 3, 2026, with listing expected on September 8, 2026, subject to the final exchange process. The Red Herring Prospectus has been filed with SEBI.
Rays of Belief IPO Details
| IPO Details | Information |
|---|---|
| Company Name | Rays of Belief Limited |
| Brand | Mom’s Belief |
| IPO Type | Mainboard IPO |
| Issue Type | Book-Built Issue |
| IPO Open Date | September 1, 2026 |
| IPO Close Date | September 3, 2026 |
| Price Band | To be announced |
| Face Value | ₹10 per share |
| Issue Size | Up to 52.30 lakh shares |
| Fresh Issue | Up to 52.30 lakh shares |
| Offer for Sale | Nil |
| Lot Size | To be announced |
| Minimum Investment | To be announced |
| Listing | BSE & NSE |
| Basis of Allotment | September 4, 2026 |
| Refund Initiation | September 7, 2026 |
| Demat Credit | September 7, 2026 |
| Expected Listing Date | September 8, 2026 |
| Promoters | Nitin Bindlish & Carving Futures Pte. Ltd. |
| Lead Manager | Mefcom Capital Markets Limited |
| Registrar | KFin Technologies Limited |
The company has reduced the proposed issue from the 60 lakh shares mentioned in its earlier draft papers to up to 52.30 lakh shares, following a pre-IPO placement of ₹5.89 crore. The pre-IPO shares were allotted at ₹284 and ₹290 per share. The final IPO price band and lot size had not been announced as of August 22, 2026, so investors should not treat those pre-IPO prices as the official IPO price band.
What Does Rays of Belief Do?
Rays of Belief operates under the Mom’s Belief brand and provides multidisciplinary intervention programmes for children with neurodevelopmental disorders. Its services cover areas including behavioural intervention, speech and language therapy, special education, developmental therapy and other support programmes designed around the individual needs of children.
Also Read: Atomberg IPO Decoded: Issue Size, Investor Exits, Financials and Key Risks
The company’s business model is different from traditional pharmaceutical or hospital companies. Instead of selling medicines or operating large hospitals, Rays of Belief operates a network of centres where children and their families receive structured intervention and developmental support.
The company began operations in 2018 and has expanded rapidly. As of March 31, 2026, it operated 136 centres across 57 cities in 20 states and Union Territories and had served more than 58,000 children since inception. According to a CARE report cited in the company’s IPO documents, Rays of Belief ranks first in India by number of centres among enterprises operating in this segment and seventh globally among listed behavioural-health players by centre count.
A notable feature of its expansion strategy is its focus on Tier-II and Tier-III cities, where access to organised neurodevelopmental care can be more limited than in major metropolitan areas.
Rays of Belief Expansion Strategy
Expansion is the central theme of the IPO.
Also Read: Lumino Industries IPO 2026: Complete Details, Price, Financials, Valuation and Risks
The company plans to establish 319 additional centres between FY2027 and FY2029. This would substantially increase its existing network of 136 centres and create a much larger national footprint. The company intends to use a combination of Company Learning Centres, centres operated in partnership with licensed professionals, School Collaboration Centres, Centres for Excellence and Research and Upskilling Academies as part of its expansion strategy.
The strategy is particularly focused on smaller cities. This gives the company an opportunity to expand into markets where organised developmental-care services may be less developed, but it also creates an execution challenge because every new centre requires trained professionals, appropriate facilities, technology and sufficient patient demand.
Why Is Rays of Belief Raising Money?
Unlike several recent IPOs where a large portion of the issue consists of an Offer for Sale, the Rays of Belief IPO is structured as a 100% fresh issue. There is no OFS component. This means the capital raised through the IPO will go toward the company’s growth and operating requirements rather than providing an exit to existing shareholders.
The company has earmarked approximately ₹41.36 crore for establishing new centres and associated technology hardware. This includes Company Learning Centres, School Collaboration Centres, a Centre for Excellence and Research and an Upskilling Academy.
Also Read: Indian IPO Market 2026: Why Investor Demand Is Surging
Around ₹14.45 crore is proposed for lease payments for existing centres in India, while approximately ₹10.13 crore is planned as an investment in its US subsidiary, Mom’s Belief US Inc., for lease and licence payments for existing US centres. Another ₹10.21 crore is earmarked for brand awareness and inclusive outreach programmes.
This allocation shows that the IPO is primarily an expansion and scale-up exercise rather than a debt-reduction story.
Financial Performance
Rays of Belief has reported rapid revenue growth, although profitability has not increased at the same pace.
Consolidated revenue from operations increased to approximately ₹81.66 crore in FY2026 from ₹36.42 crore in FY2025. However, profit after tax declined from approximately ₹5.88 crore in FY2025 to ₹4.96 crore in FY2026. The company therefore delivered strong top-line growth but experienced pressure on the bottom line.
Also Read: Annu Projects IPO 2026: Complete Details, Price, Financials, Valuation and Risks
The FY2026 financial snapshot shows total income of around ₹82.06 crore, EBITDA of approximately ₹11.91 crore and net worth of about ₹30.81 crore. Total borrowings stood at approximately ₹3.61 crore. The reported ROE was around 21.64%, ROCE around 29.74%, and EBITDA margin approximately 14.59%.
The difference between revenue and profit growth is important. Investors should not assume that rapid centre expansion will automatically translate into proportionately higher profits. New centres generally require upfront investment and may take time to reach maturity and breakeven.
A Fast-Growing but Capital-Intensive Expansion Model
Rays of Belief’s growth strategy offers significant potential, but it also introduces execution risk. Establishing 319 new centres within three years is an ambitious target compared with the existing network of 136 centres.
The company will need to recruit and retain qualified therapists, psychologists, special educators and other professionals. Maintaining consistent service quality across a rapidly expanding network will also be important because the company’s reputation and customer trust are central to its business.
Also Read: Symbiotec Pharmalab IPO 2026: Price, Date, GMP, Financials & Review
The leased-centre model can reduce the upfront capital required to establish locations compared with owning real estate, but it creates recurring rental and lease obligations. The IPO’s allocation of ₹14.45 crore toward existing Indian centre leases highlights the importance of this cost structure.
Key Strengths of Rays of Belief
One of the company’s major strengths is its position in a specialised and relatively underserved segment. Neurodevelopmental care is a highly fragmented market, and Rays of Belief has already created a sizeable network across multiple cities.
Its 136-centre network, presence across 57 cities, and more than 58,000 children served provide evidence that the company has already developed meaningful operating scale.
The company’s focus on Tier-II and Tier-III cities is another potential advantage. Instead of concentrating exclusively on large urban markets, Rays of Belief is attempting to build a national network in locations where organised services may have lower availability.
Also Read: Hy-Tech Engineers IPO 2026: Price, Date, GMP, Financials & Review
The 100% fresh issue structure is also a positive factor from a capital-allocation perspective. Existing shareholders are not selling shares through an OFS, while the IPO proceeds are being directed toward centre expansion, technology, leases, international operations and brand development.
Key Risks
The biggest risk is execution. Opening 319 centres between FY2027 and FY2029 is a very ambitious expansion programme. Delays in opening centres, lower-than-expected patient volumes or difficulty hiring qualified professionals could affect the company’s growth projections.
Another risk is the availability of skilled professionals. The quality of developmental intervention depends heavily on therapists, psychologists, special educators and other trained personnel. Rapid expansion could make recruitment and retention more challenging.
The company is also exposed to the risk of new centres taking longer than expected to reach breakeven. Expansion can initially increase operating costs before the centres generate sufficient revenue.
Also Read: Gaja Capital IPO 2026: Key Details, Growth Potential and Risks
Service quality represents another important risk. Because the business operates in a sensitive healthcare and developmental-care segment, any significant quality issue or adverse customer experience could affect the brand.
There is also limited direct peer comparison available. The company has stated that there are no listed companies in India or overseas with a business portfolio and scale of operations directly comparable to Rays of Belief. This makes valuation analysis more difficult than for an IPO from a conventional manufacturing, banking or infrastructure business.
Rays of Belief IPO Valuation
Valuation cannot yet be calculated accurately because the official IPO price band had not been announced as of August 22, 2026. Current IPO trackers also show the price band and lot size as pending confirmation.
The recent pre-IPO placement provides some context. The company raised ₹5.89 crore through pre-IPO placements at prices of ₹284 and ₹290 per share. However, these transactions should not automatically be treated as the final IPO valuation because the public issue price will be determined through the IPO process.
Also Read: Skyways Air Services IPO 2026 — India’s No. 1 Air Freight Forwarder Goes Public
Once the official price band is announced, investors should compare the implied market capitalisation with revenue, EBITDA, PAT, centre count, growth rate and future expansion requirements.
Because there is no directly comparable listed peer, investors should place greater emphasis on the company’s ability to convert rapid centre expansion into sustainable cash flows and profitability.
Should You Consider Rays of Belief IPO?
Rays of Belief is a unique IPO because it provides exposure to a specialised neurodevelopmental-care business rather than a conventional industrial or financial company.
The company has demonstrated strong revenue growth, built a sizeable national centre network and established a presence across Tier-II and Tier-III markets. Its plan to add 319 centres could create substantial operating scale if executed successfully.
Also Read: Gaja Alternative Asset Management IPO 2026
However, the business is also entering an aggressive expansion phase at a time when FY2026 profit declined despite strong revenue growth. Investors therefore need to look beyond the headline revenue CAGR and examine centre-level economics, profitability, professional availability, lease costs and cash generation.
The IPO’s final attractiveness will depend heavily on the official price band and resulting valuation. Until those details are announced, it would be premature to make a valuation-based conclusion.
For investors studying the IPO, the most important factors to monitor are the final issue price, expected valuation, centre expansion progress, profitability of new centres, operating cash flow and the company’s ability to maintain service quality while scaling.
Disclaimer: This article is for educational and informational purposes only and should not be considered investment advice or a recommendation to apply for the Rays of Belief IPO. IPO details, price band, lot size, financial information and other issue terms can change before the issue opens. Investors should read the latest RHP and verify the final IPO details before making any investment decision.
Also Read: Shankesh Jewellers IPO 2026: Should You Subscribe? Full Analysis
